CLINICAL_TRIALS
withdrawal
· 2026-01-20
Clinical Trial Update: Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation
Summary
The clinical trial evaluating hyperpolarized xenon imaging in COPD patients undergoing targeted lung denervation has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Xemed LLC | Conditions: COPD | Status: WITHDRAWN